Low vitamin D and uric acid status in patients with benign paroxysmal positional vertigo
- PMID: 37807761
- PMCID: PMC10563478
- DOI: 10.1177/00368504231205397
Low vitamin D and uric acid status in patients with benign paroxysmal positional vertigo
Abstract
Purpose: Growing evidence reported that vitamin D and uric acid metabolism played roles in the occurrence of benign paroxysmal positional vertigo, an otoconia-related vestibular disorder. We aimed to investigate the serum 25-hydroxy vitamin D (25(OH)D) and uric acid in patients with benign paroxysmal positional vertigo and to determine the risk factor for benign paroxysmal positional vertigo.
Methods: This case-control study comprised 182 patients with benign paroxysmal positional vertigo and 182 age- and gender-matched controls. All subjects' age, body mass index, systolic blood pressure, diastolic blood pressure, 25-hydroxyvitamin D (25(OH)D), uric acid and serum calcium measurements were analyzed.
Results: We found a female preponderance of benign paroxysmal positional vertigo patients, with a median of 60 (52-66) years old. The results showed low vitamin D status both in benign paroxysmal positional vertigo and controls, with no significant difference of 25(OH)D levels between benign paroxysmal positional vertigo patients and controls (P > 0.05). Compared with the control group, patients with benign paroxysmal positional vertigo had a higher prevalence of vitamin D deficiency and a lower prevalence of vitamin D sufficiency (P < 0.05). Uric acid was significantly lower in the benign paroxysmal positional vertigo groups (P < 0.05). Logistic regression analysis revealed that age and uric acid were considered higher risk predictors for benign paroxysmal positional vertigo.
Conclusion: Our study observed low vitamin D status in patients with benign paroxysmal positional vertigo, with no significant differences of the 25(OH)D level in patients with benign paroxysmal positional vertigo and controls. Elderly, vitamin D deficiency and low uric acid levels may be risk factors for benign paroxysmal positional vertigo occurrence.
Keywords: 25(OH)D; Benign paroxysmal positional vertigo; antioxidant status; uric acid; vitamin D deficiency.
Conflict of interest statement
Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Vitamin D Supplementation and Recurrence of Benign Paroxysmal Positional Vertigo.Nutrients. 2024 Feb 28;16(5):689. doi: 10.3390/nu16050689. Nutrients. 2024. PMID: 38474817 Free PMC article. Review.
-
Serum levels of 25-hydroxy vitamin D correlate with idiopathic benign paroxysmal positional vertigo.Biosci Rep. 2019 Apr 30;39(4):BSR20190142. doi: 10.1042/BSR20190142. Print 2019 Apr 30. Biosci Rep. 2019. PMID: 30962270 Free PMC article.
-
Low 25-hydroxyvitamin D levels in postmenopausal female patients with benign paroxysmal positional vertigo.Acta Otolaryngol. 2018 May;138(5):443-446. doi: 10.1080/00016489.2017.1416168. Epub 2017 Dec 22. Acta Otolaryngol. 2018. PMID: 29272984
-
Investigation of Serum Calcium and 25-Hydroxy Vitamin D Levels in Benign Paroxysmal Positional Vertigo Patients.Ear Nose Throat J. 2021 Nov;100(9):643-646. doi: 10.1177/0145561321989451. Epub 2021 Jan 25. Ear Nose Throat J. 2021. PMID: 33491490
-
Association between serum vitamin D levels and benign paroxysmal positional vertigo: a systematic review and meta-analysis of observational studies.Eur Arch Otorhinolaryngol. 2020 Jan;277(1):169-177. doi: 10.1007/s00405-019-05694-0. Epub 2019 Oct 19. Eur Arch Otorhinolaryngol. 2020. PMID: 31630244
Cited by
-
Association between vitamin D, vitamin D supplementation and benign paroxysmal positional vertigo: a systematic review and meta-analysis.Front Neurol. 2025 Apr 16;16:1560616. doi: 10.3389/fneur.2025.1560616. eCollection 2025. Front Neurol. 2025. PMID: 40308226 Free PMC article.
-
Serum Otoconin-90 and Otolin-1 Concentrations in Benign Paroxysmal Positional Vertigo.Biomolecules. 2024 Oct 10;14(10):1279. doi: 10.3390/biom14101279. Biomolecules. 2024. PMID: 39456211 Free PMC article.
-
Vitamin D Supplementation and Recurrence of Benign Paroxysmal Positional Vertigo.Nutrients. 2024 Feb 28;16(5):689. doi: 10.3390/nu16050689. Nutrients. 2024. PMID: 38474817 Free PMC article. Review.
-
Circulating levels of micronutrients and the risk of benign paroxysmal positional vertigo: A Mendelian randomization study.Heliyon. 2024 Oct 2;10(19):e38782. doi: 10.1016/j.heliyon.2024.e38782. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39430529 Free PMC article.
-
Benign paroxysmal positional vertigo a systematic review of the effects of comorbidities.Front Neurol. 2025 May 23;16:1595693. doi: 10.3389/fneur.2025.1595693. eCollection 2025. Front Neurol. 2025. PMID: 40488199 Free PMC article. Review.
References
-
- Talaat HS, Abuhadied G, Talaat ASet al. et al. Low bone mineral density and vitamin D deficiency in patients with benign positional paroxysmal vertigo. Eur Arch Otorhinolaryngol 2015; 272: 2249–2253. - PubMed
-
- Elmoursy MM, Abbas AS. The role of low levels of vitamin D as a co-factor in the relapse of benign paroxysmal positional vertigo (BPPV). Am J Otolaryngol 2021; 42: 103134. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical